Lung Cancer (ASCO 2024)

Lung Cancer (ASCO 2024)

Agenda Welcome & introduction by host Alfredo Addeo WHAT’S NEW IN TARGETED THERAPIES FOR NSCLC? XIUNING LE LATEST INSIGHTS IN ADCS FOR LUNG CANCER LIZZA HENDRIKS NEW ADVANCES IN IMMUNOTHERAPIES FOR LUNG CANCER ALFREDO ADDEO  } 1 h 32 min Get Your CME...
HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...
Biomarkers in GI & Lung

Biomarkers in GI & Lung

Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...
Early NSCLC

Early NSCLC

Early NSCLC Welcome & introduction by host Isabelle Opitz Doing more with less: state of the art in tissue acquisition Carolin Steinack Current standards for pathology reporting in lung cancer Lukas Bubendorf Recent advances in thoracic surgery in lung cancer Brendon...
Lung Cancer 2023 Review

Lung Cancer 2023 Review

Lung Cancer 2023 Review Welcome & introduction by host Solange Peters Druggable since 2023: an overview of newly approved therapies Solange Peters Highlights of the year in immunotherapies Hossein Borghaei Highlights of the year in targeted therapies Pasi Jänne  } 1...